Abstract:Background Most of the structural modifications to evodiamine (EVO) have focused on the 3- and 10-positions, while structural modifications to the EVO 2-position have not yet been reported. In this study, we investigated the scaffold diversity and bioactivity of EVO from position 2 to gain more insight into the influence of the chemical space around EVO on bioactivity. Objective The study aims to synthesize two derivatives of EVO with hydroxy groups, 8a and 8b, and to investigate the antitumor activity of EVO derivatives with hydroxy groups compared to EVO. Methods The synthesized compounds were structurally characterized by H-1 NMR, C-13 NMR, and mass spectrometry. The effects of compounds 8a, 8b, and EVO on the proliferation of H460, A549, and Eca109 cells in vitro were determined by MTT. The effect of EVO, 8a and 8b on apoptosis of H460 cells was investigated by the annexed V-FITC/propidium iodide (PI) combination assay. The expression of EVO, 8a and 8b on apoptosis-related proteins was examined by Western blot analysis. To simulate the binding ability between small molecules and proteins, molecular docking calculations of EGFR(WT) and EGFR(T790M) with 8a and 8b, respectively, were performed using Schrodinger software. Results In the cytotoxicity assay, compound 8b showed lower IC50 values for the three tumor cell lines (6.69 & mu;M for H460 cells, 20.02 & mu;M for A549 cells, and 16.47 & mu;M for Eca109 cells) compared to compound 8a and EVO, and 8b induced apoptosis by affecting apoptosis-related proteins CRAF, AKT, and ERK in a late apoptotic manner. The molecular docking results showed that 8b has a good binding ability to EGFR upstream of apoptosis-related proteins. Conclusion These findings suggest that 8b has significantly higher antitumor biological activity than EVO and 8a. This antitumor effect has important implications for the study of EVO derivatives in antitumor models.

Water-soluble Derivatives of Evodiamine: Discovery of Evodiamine-10-phosphate As an Orally Active Antitumor Lead Compound.

New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives As Novel Antitumor Agents by Systemic Structure-Activity Relationship Analysis and Biological Evaluations.

Synthesis , in vitro and in vivo antitumor activity and docking studies of new evodiamine derivatives

Identification of a novel 10-hydroxyevodiamine prodrug as a potent topoisomerase inhibitor with improved aqueous solubility for treatment of hepatocellular carcinoma

Design of Evodiamine–Glucose Conjugates with Improved in Vivo Antitumor Activity

Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activity

Evodiamine-Inspired Topoisomerase-Histone Deacetylase Dual Inhibitors: Novel Orally Active Antitumor Agents for Leukemia Therapy

Discovery of Novel Bis-Evodiamine Derivatives with Potent Antitumor Activity.

Design, Synthesis and Bioactivity Evaluation of Novel N-phenyl-substituted Evodiamine Derivatives As Potent Anti-Tumor Agents

Structure-activity Relationship Study of Novel Evodiamine Amino Acid Conjugates with Potent Anti-Colorectal Cancer Efficacy

The Design, Synthesis, and Evaluation of Evodiamine Derivatives with Hydroxy Groups

Design, synthesis, and biological evaluation of 3,4,5-trimethoxy evodiamine derivatives as potential antitumor agents

Design, synthesis and bioactivity evaluation of favorable evodiamine derivative scaffold for developing cancer therapy

Selection of evodiamine as a novel topoisomerase I inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents.

The Design, Synthesis, and Evaluation of Evodiamine Derivatives with Hydroxyl Groups

Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer.

Antiproliferative Effects of Alkaloid Evodiamine and Its Derivatives

N(14)-substituted Evodiamine Derivatives As Dual Topoisomerase 1/Tubulin-Inhibiting Anti-Gastrointestinal Tumor Agents

Design, Synthesis, and Biological Evaluation of Novel Evodiamine Derivatives As Potential Antihepatocellular Carcinoma Agents

Structural Simplification of Evodiamine: Discovery of Novel Tetrahydro-Β-carboline Derivatives As Potent Antitumor Agents.

Advances in the Research of Biological Activities of Evodiamine Derivatives